je.st
news
Tag: merck
Merck committed to Cubist after patent losses
2014-12-09 19:25:55| Biotech - Topix.net
Merck remains committed to its $8.4 billion acquisition of Cubist Pharmaceuticals even though a federal court invalidated most of the patents protecting the company's top-selling antibiotic just hours after that deal was announced Monday. Shares of both companies tumbled Tuesday morning in the first day of trading after Cubist said a federal court invalidated four patents protecting Cubicin.
Tags: committed
patent
losses
merck
Merck Statement Regarding CUBICIN Patent Litigation
2014-12-09 14:11:00| Merck.com - Corporate News
Dateline City: KENILWORTH, N.J. Company Reaffirms Transaction To Proceed as Planned; Expected to Close in First Quarter of 2015 KENILWORTH, N.J.--(BUSINESS WIRE)--Merck, known as MSD outside the United States and Canada, issued the following statement regarding the decision of the U.S. District Court for the District of Delaware. The decision, which upheld the patent for CUBICIN that expires on June 15, 2016 and invalidated four others, is subject to appeal. Language: English Contact: MerckMedia:Lainie Keller, 908-236-5036orSteve Cragle, 908-740-1801orInvestors:Joe Romanelli, 908-740-1986orJustin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: statement
patent
litigation
merck
Cramer's Mad Money - 3 Cheers For Merck
2014-12-09 13:11:45| Footwear - Topix.net
"Three cheers for Merck," said Cramer, saluting Merck's acquisition of Cubist Pharmaceuticals for $8.4 billion. The company focuses on illnesses picked up in hospitals, particularly "superbugs."
Merck dives into 'superbug' chase with Cubist
2014-12-08 17:23:28| Biotech - Topix.net
Merck will spend $8.4 billion to buy Cubist Pharmaceuticals and push deeper into treating so-called "superbugs" that have drawn dire warnings from global health organizations. The company said Monday that the deal will give it stronger footing in hospital acute care and help it address antibiotic resistance, which the Whitehouse Station, New Jersey, drugmaker called a critical area of unmet medical need.
Tags: chase
merck
dives
cubist
Merck to buy Cubist Pharmaceuticals for $9.5 billion
2014-12-08 14:13:42| Biotech - Topix.net
Drug giant Merck said it will buy Cubist and a slate of medicines administered in the hospital setting, many for bacterial infections, for about $9.5 billion, for $102 a share in cash. The deal represents a 35 percent premium to Cubist's average stock price in the last five trading days, Merck said in a statement on Monday.
Tags: buy
billion
pharmaceuticals
merck
Sites : [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] next »